Marinus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MRNS for the last quarter is 7.68 M USD, and it's 6.80% higher compared to the previous quarter. The net income of Q1 24 is -38.67 M USD.